State-of-the-art implantable cardiac assist device therapy for heart failure: Bridge to transplant and destination therapy

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 1, 2012, Pages 94-100

  Park, S J ^a   Kushwaha, S S ^a   McGregor, C G A ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASSISTED CIRCULATION; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DEVICE THERAPY; HEART ASSIST DEVICE; HEART DISEASE; HEART RIGHT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PULSATILE FLOW; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS;

EID: 84055207677     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.274     Document Type: Review

References (68)

1. Rose, E.A. et al.; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med. 345, 1435-1443 (2001).
2. Wampler, R.K., Moise, J.C., Frazier, O.H. & Olsen, D.B. In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Trans. 34, 450-454 (1988).
3. Frazier, O.H., Nakatani, T., Duncan, J.M., Parnis, S.M. & Fuqua, J.M. Clinical experience with the Hemopump. ASAIO Trans. 35, 604-606 (1989).
4. Miller, L.W. et al.; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357, 885-896 (2007). (Pubitemid 47347322)
5. Frazier, O.H. et al.; HeartMate LVAS Investigators. Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J. Thorac. Cardiovasc. Surg. 122, 1186-1195 (2001).
6. Slaughter, M.S. et al.; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 361, 2241-2251 (2009).
7. Fang, J.C. Rise of the machines-left ventricular assist devices as permanent therapy for advanced heart failure. New England Journal of Medicine 361(23), 2282-2285 (2009).
8. Kirklin, J.K. et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J. Heart Lung Transplant. 29, 1-10 (2010).
9. Kirklin, J.K. et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J. Heart Lung Transplant. 30, 115-123 (2011).
10. Kirklin, J.K. et al. INTERMACS database for durable devices for circulatory support: first annual report. J. Heart Lung Transplant. 27, 1065-1072 (2008).
11. Strueber, M., O'Driscoll, G., Jansz, P., Khaghani, A., Levy, W.C. & Wieselthaler, G.M.; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J. Am. Coll. Cardiol. 57, 1375-1382 (2011).
12. Stevenson, L.W. et al. INTERMACS profiles of advanced heart failure: the current picture. J. Heart Lung Transplant. 28, 535-541 (2009).
13. Boyle, A.J. et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J. Heart Lung Transplant. 30, 402-407 (2011).
14. Lietz, K. et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116, 497-505 (2007). (Pubitemid 47450258)
15. Levy, W.C., Mozaffarian, D., Linker, D.T., Farrar, D.J. & Miller, L.W.; REMATCH Investigators. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J. Heart Lung Transplant. 28, 231-236 (2009).
16. Stehlik, J. et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J. Heart Lung Transplant. 29, 1089-1103 (2010).
17. John, R. et al. Post-cardiac transplant survival after support with a continuousflow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J. Thorac. Cardiovasc. Surg. 140, 174-181 (2010).
18. Rogers, J.G. et al.; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J. Am. Coll. Cardiol. 55, 1826-1834 (2010).
19. Kormos, R.L. et al.; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J. Thorac. Cardiovasc. Surg. 139, 1316-1324 (2010).
20. Topilsky, Y. et al. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC. Cardiovasc. Imaging 4, 211-222 (2011).
21. Klovaite, J., Gustafsson, F., Mortensen, S.A., Sander, K. & Nielsen, L.B. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J. Am. Coll. Cardiol. 53, 2162-2167 (2009).
22. Crow, S. et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann. Thorac. Surg. 90, 1263-1269; discussion 1269 (2010).
23. Crow, S. et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg. 137, 208-215 (2009).
24. Boyle, A.J. et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J. Heart Lung Transplant. 28, 881-887 (2009).
25. Studer, M.A. et al. An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent. J. Heart Lung Transplant. 25, 857-861 (2006). (Pubitemid 43983061)
26. Thomas, M.D., Wood, C., Lovett, M., Dembo, L. & O'Driscoll, G. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J. Heart Lung Transplant. 27, 925-927 (2008). (Pubitemid 352024419)
27. Rothenburger, M. et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 106, I189-I192 (2002).
28. Delgado, R. 3rd et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J. Heart Lung Transplant. 24, 231-233 (2005).
29. Saito, S. et al. End-organ function during chronic nonpulsatile circulation. Ann. Thorac. Surg. 74, 1080-1085 (2002). (Pubitemid 35176721)
30. Kihara, S. et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann. Thorac. Surg. 75, 178-183; discussion 183 (2003). (Pubitemid 36099043)
31. Russell, S.D. et al.; HeartMate II Clinical Investigators. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120, 2352-2357 (2009).
32. Liao, K.K. et al. Timing of transesophageal echocardiography in diagnosing patent foramen ovale in patients supported with left ventricular assist device. Ann. Thorac. Surg. 75, 1624-1626 (2003). (Pubitemid 36515255)
33. Nguyen, D.Q., Das, G.S., Grubbs, B.C., Bolman, R.M. 3rd & Park, S.J. Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support. J. Heart Lung Transplant. 18, 1021-1023 (1999). (Pubitemid 29506523)
34. Hong, J., Park, S.J., Mankad, S.V., Cetta, F. Jr, Torres, N.E. & Brown, M.L. Hypoxemia after an axial flow pump Jarvik-2000 implantation: catheter induced. J. Thorac. Cardiovasc. Surg. 136, 1082-1083 (2008).
35. Park, S.J., Liao, K.K., Segurola, R., Madhu, K.P. & Miller, L.W. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J. Thorac. Cardiovasc. Surg. 127, 264-266 (2004). (Pubitemid 38160493)
36. Cohn, W.E., Demirozu, Z.T. & Frazier, O.H. Surgical closure of left ventricular outflow tract after left ventricular assist device implantation in patients with aortic valve pathology. J. Heart Lung Transplant. 30, 59-63 (2011).
37. Topilsky, Y. et al. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J. Am. Soc. Echocardiogr. 24, 157-169 (2011).
38. Tasset, M.R., Kavarana, M.N., Gray, L.A. & Dowling, R.D. Simple mechanical aortic valve closure in ventricular assist device recipients. Ann. Thorac. Surg. 82, 316-318 (2006).
39. Topilsky, Y. et al. Mitral valve regurgitation in patients supported on continuous flow pumps. Echocardiography (2011).
40. Piacentino, V. 3rd et al. Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. The Annals of Thoracic Surgery 91(5), 1342-1347 (2011).
41. Saeed, D. et al. Tricuspid valve repair with left ventricular assist device implantation: is it warranted? J. Heart Lung Transplant. 30, 530-535 (2011).
42. Maltais, S. et al. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices. J. Thorac. Cardiovasc. Surg. (2011); e-pub ahead of print 10 August 2011.
43. Lietz, K. et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J. Thorac. Cardiovasc. Surg. 137, 1012-1019 (2009).
44. Sareyyupoglu, B. et al. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J. 56, 527-531 (2010).
45. Topilsky, Y. et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123, 1929-1939 (2011).
46. Wiklund, L., Svensson, S. & Berggren, H. Implantation of a left ventricular assist device, back-to-front, in an adolescent with a failing mustard procedure. J. Thorac. Cardiovasc. Surg. 118, 755-756 (1999). (Pubitemid 29474808)
47. Stewart, A.S., Gorman, R.C., Pocchetino, A., Rosengard, B.R. & Acker, M.A. Left ventricular assist device for right side assistance in patients with transposition. Ann. Thorac. Surg. 74, 912-914 (2002). (Pubitemid 35001830)
48. Joyce, D.L. et al. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J. Heart Lung Transplant. 29, 1302-1305 (2010).
49. Frazier, O.H., Gregoric, I.D. & Messner, G.N. Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure. Tex. Heart Inst. J. 32, 402-404 (2005). (Pubitemid 41306806)
50. Durham, L.A. et al. Application of computer modeling in systemic VAD support of failing Fontan physiology. World J. Pediatr. Congenit. Heart Surg. 2, 243-248 (2011).
51. Saito, S. et al. Biventricular support using implantable continuous-flow ventricular assist devices. J. Heart Lung Transplant. 30, 475-478 (2011).
52. Hetzer, R., Krabatsch, T., Stepanenko, A., Hennig, E. & Potapov, E.V. Long-term biventricular support with the heartware implantable continuous flow pump. J. Heart Lung Transplant. 29, 822-824 (2010).
53. Loforte, A., Montalto, A., Della Monica, P.L., Contento, C. & Musumeci, F. Biventricular support with the HeartWare implantable continuous flow pump: an additional contribution. J. Heart Lung Transplant. 29, 1443-1444 (2010).
54. Strueber, M., Meyer, A.L., Malehsa, D. & Haverich, A. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J. Thorac. Cardiovasc. Surg. 140, 936-937 (2010).
55. Stulak, J.M., Griffith, K.E., Nicklas, J.M. & Pagani, F.D. The use of the HeartWare HVAD for long-term right ventricular support after implantation of the HeartMate II device. J. Thorac. Cardiovasc. Surg. 142, e140-e142 (2011).
56. Loebe, M. et al. Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc. J. 7, 40-44 (2011).
57. Baldwin, J.T. & Mann, D.L. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J. Card. Fail. 16, 855-858 (2010).
58. Heerdt, P.M. et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102, 2713-2719 (2000).
59. Terracciano, C.M. et al. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur. Heart J. 24, 1329-1339 (2003). (Pubitemid 36917704)
60. Park, S.J. et al. Myocardial creatine kinase expression after left ventricular assist device support. J. Am. Coll. Cardiol. 39, 1773-1779 (2002). (Pubitemid 34595287)
61. Torre-Amione, G. et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100, 1189-1193 (1999). (Pubitemid 29426594)
62. Goldstein, D.J. et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann. Thorac. Surg. 63, 971-974 (1997). (Pubitemid 27191646)
63. Corry, D.C. et al. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J. 44, M347-M351 (1998). (Pubitemid 28468854)
64. James, K.B. et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92, II191-II195 (1995).
65. Zafeiridis, A., Jeevanandam, V., Houser, S.R. & Margulies, K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98, 656-662 (1998). (Pubitemid 28387492)
66. Maybaum, S. et al.; LVAD Working Group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115, 2497-2505 (2007). (Pubitemid 46763223)
67. Birks, E.J. et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N. Engl. J. Med. 355, 1873-1884 (2006). (Pubitemid 44664645)
68. Birks, E.J. et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation 123, 381-390 (2011).